Keyphrases
RNA-based Therapeutics
100%
Alpha-synuclein (α-syn)
100%
Parkinson's Disease
100%
Disease-modifying Therapy
50%
Small Molecules
50%
Identification Strategy
25%
Pathologic
25%
Cell Biology
25%
Neurodegeneration
25%
Biological Activity
25%
Lead Identification
25%
New Drug Targets
25%
Human Genetics
25%
Target RNA
25%
Large-scale Clinical Trial
25%
Further Development
25%
Disease Progression
25%
Animal Model Study
25%
Unmet Medical Need
25%
Therapeutic Target
25%
Dementia
25%
Disease Development
25%
Molecular Pathogenesis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Synuclein
100%
Parkinson's Disease
100%
Diseases
100%
Disease Exacerbation
25%
Biological Activity
25%
Disease Course
25%
Nerve Degeneration
25%
Molecular Pathology
25%
Clinical Trial
25%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Synuclein
100%
Small Molecule
50%
Animal Model
25%
Human Genetics
25%
Clinical Trial
25%
Biological Activity
25%